Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0247 Transporter Info | ||||
| Gene Name | SLC29A1 | ||||
| Transporter Name | Equilibrative nucleoside transporter 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | N6-cyclopentyladenosine Drug Info | ||||
| Xenobiotic Type | Investigative Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 657378 | ||||
| Docking Score | -9.672 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C15H21N5O4 | ||||
| Molecular Weight | 335.36 | ||||
| Canonical SMILES |
C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O
|
||||
| InChI |
InChI=1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1
|
||||
| InChIKey | SQMWSBKSHWARHU-SDBHATRESA-N | ||||
| Pharmaceutical Properties | Xlogp | 0.9 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 8 | ||
| Xenobiotic Name | Tecadenoson Drug Info | ||||
| Xenobiotic Type | Discontinued Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 158795 | ||||
| Docking Score | -9.218 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C14H19N5O5 | ||||
| Molecular Weight | 337.33 | ||||
| Canonical SMILES |
C1COC[C@@H]1NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O
|
||||
| InChI |
InChI=1S/C14H19N5O5/c20-3-8-10(21)11(22)14(24-8)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-23-4-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t7-,8-,10-,11-,14-/m1/s1
|
||||
| InChIKey | OESBDSFYJMDRJY-BAYCTPFLSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.3 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 9 | ||
| Xenobiotic Name | Adenosine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 60961 | ||||
| Docking Score | -8.539 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C10H13N5O4 | ||||
| Molecular Weight | 267.24 | ||||
| Canonical SMILES |
C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N
|
||||
| InChI |
InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
|
||||
| InChIKey | OIRDTQYFTABQOQ-KQYNXXCUSA-N | ||||
| Pharmaceutical Properties | Xlogp | -1.1 | Rotatable Bond Count | 2 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 8 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.